0000899243-16-012466.txt : 20160201
0000899243-16-012466.hdr.sgml : 20160201
20160201185529
ACCESSION NUMBER: 0000899243-16-012466
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160128
FILED AS OF DATE: 20160201
DATE AS OF CHANGE: 20160201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: .
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-531-5965
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Holmes Scott A
CENTRAL INDEX KEY: 0001537670
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 161378768
MAIL ADDRESS:
STREET 1: C/O KERYX BIOPHARMACEUTICALS INC
STREET 2: 1 MARINA PARK DR., 10TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-28
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001537670
Holmes Scott A
C/O KERYX BIOPHARMACEUTICALS, INC.
ONE MARINA PARK DRIVE, 12TH FLOOR
BOSTON
MA
02210
0
1
0
0
Chief Financial Officer
Common Stock
2016-01-28
4
A
0
53750
0.00
A
113492
D
Employee Stock Option (Right to Buy)
3.35
2016-01-28
4
A
0
107500
0.00
A
2017-01-28
2026-01-28
Common Stock
107500
107500
D
The 53,750 shares are restricted common stock, with one-third of the 53,750 shares vesting on January 28, 2017 and one-twelfth vesting on each of April 28, 2017, July 28, 2017, October 28, 2017, January 28, 2018, April 28, 2018, July 28, 2018, October 28, 2018, and January 28, 2019.
Includes 98,750 shares of restricted stock.
The options vest according to the following schedule: one-third of the 107,500 options will vest on January 28, 2017 and one-twelfth will vest on each of April 28, 2017, July 28, 2017, October 28, 2017, January 28, 2018, April 28, 2018, July 28, 2018, October 28, 2018, and January 28, 2019.
/s/ Brian Adams
2016-02-01